Jakinibs Market

Jakinibs are a type of medication that functions by inhibiting the activity of one or more of the Janus kinase family of enzymes (JAK1, JAK2, JAK3, TYK2), thereby interfering with the JAK-STAT signaling pathway.
Jakinibs Market contains market size and forecasts of Jakinibs in global, including the following market information:
Global Jakinibs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Jakinibs Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Jakinibs companies in 2021 (%)
The global Jakinibs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Autoimmune disorders Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Jakinibs include Astellas Pharma, Inc., Eli Lilly and Co., Incyte Corp., Novartis AG and Pfizer Inc., etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Jakinibs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Jakinibs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Jakinibs Market Segment Percentages, by Type, 2021 (%)
Autoimmune disorders
Oncology
Global Jakinibs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Jakinibs Market Segment Percentages, by Application, 2021 (%)
Clinics
Hospitals
Global Jakinibs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Jakinibs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Jakinibs revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Jakinibs revenues share in global market, 2021 (%)
Key companies Jakinibs sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Jakinibs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Astellas Pharma, Inc.
Eli Lilly and Co.
Incyte Corp.
Novartis AG
Pfizer Inc.